Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...

Fact checked by Nick Blackmer A new analysis of Reddit posts suggests some people may be experiencing symptoms not listed on GLP-1 drug labels.Fatigue and menstrual irregularities were among the newly ...

Just a few years after some TikTok videos spiked the demand, one in eight US adults has tried Ozempic (semaglutide) or another drug in its class. Glucagon-like peptide 1 (GLP-1) receptor agonist ...

The most common side effects of GLP-1 medications like Ozempic and Wegovy are gastrointestinal (GI) issues, including nausea, vomiting, and diarrhea. Those side effects may persist during treatment.

April 10 (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe. The ...

According to the Longevity Biotechnology Association, a global nonprofit focused on preventing diseases associated with aging and extending people’s health spans, longevity drugs are medications that ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...